10.6084/m9.figshare.5798352.v1
Sarah Biedermann
Sarah
Biedermann
Daniel Biedermann
Daniel
Biedermann
Frederike Wenzlaff
Frederike
Wenzlaff
Tim Kurjak
Tim
Kurjak
Sawis Nouri
Sawis
Nouri
Matthias Auer
Matthias
Auer
Klaus Wiedemann
Klaus
Wiedemann
Peer Briken
Peer
Briken
Jan Haaker
Jan
Haaker
Tina Lonsdorf
Tina
Lonsdorf
Johannes Fuss
Johannes
Fuss
Additional file 9: Table S7. of An elevated plus-maze in mixed reality for studying human anxiety-related behavior
Springer Nature
2017
Virtual reality
Approach
Avoidance
Risk assessment
Behavioral assay
Anxiety disorder
Acrophobia
Sensation seeking
Yohimbine
Lorazepam
2017-12-21 05:00:00
Journal contribution
https://springernature.figshare.com/articles/journal_contribution/Additional_file_9_Table_S7_of_An_elevated_plus-maze_in_mixed_reality_for_studying_human_anxiety-related_behavior/5798352
Side effects after medication in Study 2. Data were collected directly before behavioral testing (i.e., 55Â min after medication). (DOCX 19 kb)